BDBM63245 2-(1-benzimidazolyl)acetic acid [2-[3-(dimethylsulfamoyl)-4-methylanilino]-2-oxoethyl] ester::2-(benzimidazol-1-yl)acetic acid [2-[3-(dimethylsulfamoyl)-4-methyl-anilino]-2-keto-ethyl] ester::MLS000374487::SMR000242403::[2-[3-(dimethylsulfamoyl)-4-methylanilino]-2-oxoethyl] 2-(benzimidazol-1-yl)acetate::[2-[[3-(dimethylsulfamoyl)-4-methyl-phenyl]amino]-2-oxidanylidene-ethyl] 2-(benzimidazol-1-yl)ethanoate::cid_5031637

SMILES COc1cc(Nc2nc(-c3ccc4cn[nH]c4c3)cn3ncnc23)ccc1N1CCN(CC(F)(F)F)CC1

InChI Key InChIKey=KDFYJWZMMUCLLF-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63245   

TargetTyrosine-protein kinase SYK(Human)
Nanjing Ruijie Pharma Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 63245BDBM63245(6-(1H-indazol-6-yl)-N-(3-methoxy-4-(4-(2,2,2-trifl...)
Affinity DataIC50: 50nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent